Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational study

BACKGROUND: Efficacy, tolerability and safety of the novel preservative-free fixed combination of tafluprost 0.0015%/timolol 0.5% (Taptiqom(®)) were investigated in an observational study in Germany. OBJECTIVE: To assess efficacy, tolerability and safety of the preservative-free fixed combination of...

Descripción completa

Detalles Bibliográficos
Autores principales: Pillunat, Lutz E, Erb, Carl, Ropo, Auli, Kimmich, Friedemann, Pfeiffer, Norbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472425/
https://www.ncbi.nlm.nih.gov/pubmed/28652689
http://dx.doi.org/10.2147/OPTH.S128453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472425/
https://www.ncbi.nlm.nih.gov/pubmed/28652689
http://dx.doi.org/10.2147/OPTH.S128453

Ejemplares similares